Literature DB >> 35380877

The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17.

Daniele Chaves-Moreira1, Marilyn A Mitchell1, Cristina Arruza1, Priyanka Rawat1, Simone Sidoli2, Robbin Nameki3,4, Jessica Reddy3,4, Rosario I Corona3,4, Lena K Afeyan5,6, Isaac A Klein5,7, Sisi Ma8, Boris Winterhoff9, Gottfried E Konecny10, Benjamin A Garcia2, Donita C Brady11,12, Kate Lawrenson3,13, Patrice J Morin1, Ronny Drapkin1.   

Abstract

PAX8 is a master transcription factor that is essential during embryogenesis and promotes neoplastic growth. It is expressed by the secretory cells lining the female reproductive tract, and its deletion during development results in atresia of reproductive tract organs. Nearly all ovarian carcinomas express PAX8, and its knockdown results in apoptosis of ovarian cancer cells. To explore the role of PAX8 in these tissues, we purified the PAX8 protein complex from nonmalignant fallopian tube cells and high-grade serous ovarian carcinoma cell lines. We found that PAX8 was a member of a large chromatin remodeling complex and preferentially interacted with SOX17, another developmental transcription factor. Depleting either PAX8 or SOX17 from cancer cells altered the expression of factors involved in angiogenesis and functionally disrupted tubule and capillary formation in cell culture and mouse models. PAX8 and SOX17 in ovarian cancer cells promoted the secretion of angiogenic factors by suppressing the expression of SERPINE1, which encodes a proteinase inhibitor with antiangiogenic effects. The findings reveal a non-cell-autonomous function of these transcription factors in regulating angiogenesis in ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35380877      PMCID: PMC9135381          DOI: 10.1126/scisignal.abm2496

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   9.517


  55 in total

1.  Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1.

Authors:  S Stefansson; E Petitclerc; M K Wong; G A McMahon; P C Brooks; D A Lawrence
Journal:  J Biol Chem       Date:  2000-11-16       Impact factor: 5.157

Review 2.  It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.

Authors:  Ruth Perets; Ronny Drapkin
Journal:  Cancer Res       Date:  2015-12-15       Impact factor: 12.701

3.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.

Authors:  Jürgen Cox; Matthias Mann
Journal:  Nat Biotechnol       Date:  2008-11-30       Impact factor: 54.908

4.  Histone Acetyltransferase p300 Induces De Novo Super-Enhancers to Drive Cellular Senescence.

Authors:  Payel Sen; Yemin Lan; Catherine Y Li; Simone Sidoli; Greg Donahue; Zhixun Dou; Brian Frederick; Qijun Chen; Lacey J Luense; Benjamin A Garcia; Weiwei Dang; F Bradley Johnson; Peter D Adams; David C Schultz; Shelley L Berger
Journal:  Mol Cell       Date:  2019-02-14       Impact factor: 17.970

5.  The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin.

Authors:  S Stefansson; D A Lawrence
Journal:  Nature       Date:  1996-10-03       Impact factor: 49.962

Review 6.  Unraveling the Mysteries of PAX8 in Reproductive Tract Cancers.

Authors:  Daniele Chaves-Moreira; Patrice J Morin; Ronny Drapkin
Journal:  Cancer Res       Date:  2020-12-23       Impact factor: 13.312

7.  OCT4 and PAX6 determine the dual function of SOX2 in human ESCs as a key pluripotent or neural factor.

Authors:  Shuchen Zhang; Emma Bell; Huihan Zhi; Sarah Brown; Siti A M Imran; Véronique Azuara; Wei Cui
Journal:  Stem Cell Res Ther       Date:  2019-04-18       Impact factor: 6.832

8.  Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions.

Authors:  Ren-Chin Wu; Pei Wang; Shiou-Fu Lin; Ming Zhang; Qianqian Song; Tiffany Chu; Brant G Wang; Robert J Kurman; Russell Vang; Kenneth Kinzler; Cristian Tomasetti; Yuchen Jiao; Ie-Ming Shih; Tian-Li Wang
Journal:  J Pathol       Date:  2019-02-15       Impact factor: 7.996

9.  Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy.

Authors:  José M García-Heredia; Eva M Verdugo Sivianes; Antonio Lucena-Cacace; Sonia Molina-Pinelo; Amancio Carnero
Journal:  Oncotarget       Date:  2016-09-27

10.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

View more
  1 in total

Review 1.  PAX8 in the Junction between Development and Tumorigenesis.

Authors:  Reli Rachel Kakun; Zohar Melamed; Ruth Perets
Journal:  Int J Mol Sci       Date:  2022-07-03       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.